Make Better Decisions

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Deloitte
Citi
Teva
Colorcon
Dow
Express Scripts
Baxter
US Army
QuintilesIMS
Fuji

Generated: January 21, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 202312

« Back to Dashboard

Summary for 202312
Tradename:IBUPROFEN
Applicant:Granules India Ltd
Ingredient:ibuprofen
Patents:0
Therapeutic Class:Analgesics
Anti-inflammatory Agents
Formulation / Manufacturing:see details
Suppliers and Packaging for NDA: 202312
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
IBUPROFEN ibuprofen TABLET;ORAL 202312 ANDA Athlete's Needs, Inc. 53185-381 53185-381-01 100 TABLET, COATED in 1 BOTTLE (53185-381-01)
IBUPROFEN ibuprofen TABLET;ORAL 202312 ANDA Granules India Limited 62207-357 62207-357-43 100 TABLET in 1 BOTTLE (62207-357-43)

Profile for product number 001

Active Rx/OTC/Discontinued:OTCDosage:TABLET;ORALStrength200MG
Approval Date:Oct 7, 2016TE:RLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Covington
Farmers Insurance
Deloitte
Moodys
Chubb
McKesson
UBS
Cantor Fitzgerald
Accenture

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot